biote Corp.

Biote Corp., the hormone optimization and wellness company, completed its de-SPAC transaction with Haymaker Acquisition Corp. 4, which traded under the ticker HYAC and was sponsored by Haymaker Partners. The blank-check vehicle originally went public in 2021, targeting opportunities in the healthcare and consumer wellness sector. Biote filed an S-1 registration statement on August 1, 2022, bearing accession number 0001193125-22-207018, as part of the regulatory process surrounding the business combination. The combined company operates in the hormone health and therapeutics space, offering subcutaneous pellet therapy through a network of certified practitioners. Sign up at SpacDesk for full filing history, timeline data, and sponsor details on HYAC and thousands of other SPAC transactions.